INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 92 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 3.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $556,000 | +164.8% | 70,903 | +133.8% | 0.02% | +200.0% |
| Q4 2016 | $210,000 | +8.2% | 30,326 | +45.8% | 0.01% | 0.0% |
| Q3 2016 | $194,000 | -82.4% | 20,795 | -82.5% | 0.01% | -78.3% |
| Q2 2016 | $1,101,000 | +825.2% | 119,158 | +771.0% | 0.02% | +666.7% |
| Q1 2016 | $119,000 | -76.1% | 13,681 | -81.5% | 0.00% | -62.5% |
| Q4 2015 | $497,000 | +109.7% | 74,002 | +80.7% | 0.01% | +100.0% |
| Q3 2015 | $237,000 | +22.2% | 40,964 | +71.9% | 0.00% | +33.3% |
| Q2 2015 | $194,000 | -34.2% | 23,832 | -34.0% | 0.00% | -50.0% |
| Q1 2015 | $295,000 | +98.0% | 36,133 | +122.6% | 0.01% | +200.0% |
| Q4 2014 | $149,000 | -34.6% | 16,233 | -30.0% | 0.00% | -50.0% |
| Q3 2014 | $228,000 | +9.6% | 23,195 | +20.4% | 0.00% | +33.3% |
| Q2 2014 | $208,000 | – | 19,266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |